Evonik punishes both Geschäftsbereiche

ESSEN (dpa-AFX) – Der Spezialchemicalkonzern Evonik treibt seinen Umbau with de Straffung zwier Geschäftsbereiche voran. The coating and adhesive resin segments in healthcare are based on their core business on the MDax concept in leisure. The Randbereiche sollen überwiegend verkauft or in Partnersschaften were brought into existence, in Einzelfällen würden the Geschäfte sozialverträglich eingstellt. This Bereiche is worth an amount of 350 million euros. Zum Vergleich: 2024 gauges Evonik-Chef Christian Kullmann Konzernerlöse zwischen 15 und 17 Billiarden Euro an.

“Our branch is sure to be well-rounded in its basic structure,” said Kullmann. The resources are removed from the range in the most competitive manner. “I believe that this is so: for history, which will not contain a day of Evonik, the content of the content of Evonik will not change.”

The healthcare segment could increase the quality of the lipids for mRNA and gene therapies, the system of the freisetzung of Wirkstoffen and the inhalable substance for the treatment of drugs. The Coating & Adhesive Resins segment has been developed based on the core: Zum a liquid polybutadiene as an additive for Kleb- and Dichtstof or Autoreifen, for other Special-Acrylate for the Medizintechnik and Packaging Industry./mis/stk